86 related articles for article (PubMed ID: 7613556)
21. Epidemiological factors in clinical trial design.
Wassilak S
Dev Biol Stand; 1998; 95():75-83. PubMed ID: 9855417
[TBL] [Abstract][Full Text] [Related]
22. Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective.
Ando Y; Hamasaki T
Pharm Stat; 2010; 9(3):190-200. PubMed ID: 20737442
[TBL] [Abstract][Full Text] [Related]
23. Depression and randomized, controlled trials: problems and solutions.
Hatcher S
Expert Rev Neurother; 2006 Jan; 6(1):41-6. PubMed ID: 16466310
[TBL] [Abstract][Full Text] [Related]
24. Randomized concentration-controlled trials: motivations, use, and limitations.
Kraiczi H; Jang T; Ludden T; Peck CC
Clin Pharmacol Ther; 2003 Sep; 74(3):203-14. PubMed ID: 12966364
[No Abstract] [Full Text] [Related]
25. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
26. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
[TBL] [Abstract][Full Text] [Related]
27. Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.
Wang SJ; O'Neill RT; Hung HJ
Clin Trials; 2010 Oct; 7(5):525-36. PubMed ID: 20595242
[TBL] [Abstract][Full Text] [Related]
28. Drug research: from the idea to the product.
Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
[TBL] [Abstract][Full Text] [Related]
29. [The limits of controlled clinical studies: the case of rheumatology].
Portioli I
Ann Ital Med Int; 2000; 15(1):39-46. PubMed ID: 10842890
[TBL] [Abstract][Full Text] [Related]
30. A logistic dose-ranging method for phase I clinical investigations trials.
Murphy JR; Hall DL
J Biopharm Stat; 1997 Nov; 7(4):635-47. PubMed ID: 9358335
[TBL] [Abstract][Full Text] [Related]
31. Baseline balance and conditional size: a reply to Overall et al.
Senn S
J Biopharm Stat; 1996 May; 6(2):201-10. PubMed ID: 8732914
[TBL] [Abstract][Full Text] [Related]
32. The use of generalized tests in medical research.
Ogenstad S
J Biopharm Stat; 1998 Nov; 8(4):497-508. PubMed ID: 9855030
[No Abstract] [Full Text] [Related]
33. Directional decision for a two-tailed alternative.
Hauschke D; Steinijans VW
J Biopharm Stat; 1996 May; 6(2):211-8. PubMed ID: 8732915
[No Abstract] [Full Text] [Related]
34. [Statistical design in clinical trials].
Terahisa S
Nihon Geka Gakkai Zasshi; 2012 Aug; 113 Suppl 3():36-7. PubMed ID: 23155530
[No Abstract] [Full Text] [Related]
35. Concentration-controlled versus concentration-defined clinical trials.
Levy G
Clin Pharmacol Ther; 1993 Mar; 53(3):385-8. PubMed ID: 8453859
[No Abstract] [Full Text] [Related]
36. Considerations for Evaluating Treatment Effects From Randomized Clinical Trials.
Ruberg SJ; Akacha M
Clin Pharmacol Ther; 2017 Dec; 102(6):917-923. PubMed ID: 28891044
[TBL] [Abstract][Full Text] [Related]
37. The impact of covariate imbalance on the size of the logrank test in randomized clinical trials by N. Kinukawa, T. Nakamura, K. Akazawa and Y. Nose, Statistics in Medicine 2000; 19: 1955-1967.
Mazumdar M
Stat Med; 2002 Apr; 21(8):1167; author reply 1167-71. PubMed ID: 11933040
[No Abstract] [Full Text] [Related]
38. Bilateral procedures in randomised controlled trials.
Morris RW
J Bone Joint Surg Br; 1993 Sep; 75(5):675-6. PubMed ID: 8376419
[No Abstract] [Full Text] [Related]
39. Statistics Commentary Series: Commentary No. 31: The Uses and Misuses of the Analysis of Covariance.
Streiner DL
J Clin Psychopharmacol; 2019; 39(2):97-99. PubMed ID: 30724761
[No Abstract] [Full Text] [Related]
40. [Abecedary of the "Annales". Part 9].
Slim K
Ann Chir; 2006 Jan; 131(1):73-5. PubMed ID: 16468120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
